IgG1 antibodies to acetylcholine receptors in 'seronegative'myasthenia gravis
Only around 80% of patients with generalized myasthenia gravis (MG) have serum
antibodies to acetylcholine receptor [AChR; acetylcholine receptor antibody positive …
antibodies to acetylcholine receptor [AChR; acetylcholine receptor antibody positive …
[HTML][HTML] Rhabdomyolysis after COVID-19 infection: a case report and review of the literature
M Bawor, S Sairam, R Rozewicz, S Viegas… - Viruses, 2022 - mdpi.com
Rhabdomyolysis is a condition in which muscle breaks down potentially leading to renal
dysfunction, and often occurs secondary to a precipitating factor. Viral or bacterial infections …
dysfunction, and often occurs secondary to a precipitating factor. Viral or bacterial infections …
Serological and experimental studies in different forms of myasthenia gravis
Antibodies to the acetylcholine receptor (AChR) have been recognized for over 40 years
and have been important in the diagnosis of myasthenia gravis (MG), and its recognition in …
and have been important in the diagnosis of myasthenia gravis (MG), and its recognition in …
[HTML][HTML] COVID-19-associated risks and effects in myasthenia gravis (CARE-MG)
During the COVID-19 pandemic, patients with neuromuscular disorders, especially patients
with autoimmune myasthenia gravis, might be at greater risk of worse outcomes than other …
with autoimmune myasthenia gravis, might be at greater risk of worse outcomes than other …
[HTML][HTML] Passive and active immunization models of MuSK-Ab positive myasthenia: electrophysiological evidence for pre and postsynaptic defects
S Viegas, L Jacobson, P Waters, J Cossins… - Experimental …, 2012 - Elsevier
Antibodies directed against the post-synaptic neuromuscular junction protein, muscle
specific kinase (MuSK) are found in a small proportion of generalized myasthenia gravis …
specific kinase (MuSK) are found in a small proportion of generalized myasthenia gravis …
Presence and pathogenic relevance of antibodies to clustered acetylcholine receptor in ocular and generalized myasthenia gravis
Background Clustered acetylcholine receptor antibodies (clustered AChR-Abs) have been
detected in a proportion of patients with previously “seronegative”(SN) generalized …
detected in a proportion of patients with previously “seronegative”(SN) generalized …
Myasthenia gravis seronegative for acetylcholine receptor antibodies
Antibodies to muscle‐specific kinase (MuSK) are found in a variable proportion of patients
with myasthenia without typical acetylcholine receptor (AChR) antibodies, but their …
with myasthenia without typical acetylcholine receptor (AChR) antibodies, but their …
MuSK antibody–associated myasthenia gravis with SARS-CoV-2 infection: a case report
L Muhammed, A Baheerathan, M Cao… - Annals of Internal …, 2021 - acpjournals.org
Background: Reports about the neurologic consequences of coronavirus disease 2019
(COVID-19) describe more cases of central than peripheral nervous system involvement …
(COVID-19) describe more cases of central than peripheral nervous system involvement …
Clinically biphasic myasthenia gravis with both AChR and MuSK antibodies
S Rajakulendran, S Viegas, J Spillane, RS Howard - Journal of neurology, 2012 - Springer
A humoral basis for myasthenia gravis was established in the 1970s following the
identification of pathogenic antibodies directed against the post-synaptic acetylcholine …
identification of pathogenic antibodies directed against the post-synaptic acetylcholine …
Myasthenia gravis and other neuromuscular junction disorders
S Jacob, S Viegas, D Lashley, D Hilton-Jones - Practical Neurology, 2009 - pn.bmj.com
Myasthenia gravis is the most common autoimmune disease affecting the neuromuscular
junction and is characterised by painless fatigable muscle weakness. It is caused by …
junction and is characterised by painless fatigable muscle weakness. It is caused by …